Search research articles
Contact Us
Filters
Showing results (1-10 of 156) with videos related to
Page
of 16
Sort By:
Molecular Biotechnology
|
February 7, 2004
Infection by Shiga toxin-producing Escherichia coli: an overview
Mohamed A Karmali
Prostaglandins, Leukotrienes, and Medicine
|
October 1, 1987
Modulation of arachidonic acid metabolism in experimental arthritis induced by Salmonella enteritidis. I. Effect of ibuprofen and flurbiprofen on experimental arthritis induced by Salmonella enteritidis
R A Karmali
Kidney International. Supplement
|
January 31, 2009
Host and pathogen determinants of verocytotoxin-producing Escherichia coli-associated hemolytic uremic syndrome
Mohamed A Karmali
Cancer Biochemistry Biophysics
|
June 1, 1984
Growth inhibition and prostaglandin metabolism in the R3230AC mammary adenocarcinoma by reduced glutathione
R A Karmali
Prostaglandins and Medicine
|
July 1, 1980
Review: prostaglandins and cancer
R A Karmali
Nutrition (Burbank, Los Angeles County, Calif.)
|
January 1, 1996
Historical perspective and potential use of n-3 fatty acids in therapy of cancer cachexia
R A Karmali
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 18, 2016
Emerging Public Health Challenges of Shiga Toxin-Producing Escherichia coli Related to Changes in the Pathogen, the Population, and the Environment
Mohamed A Karmali
International Journal of Medical Microbiology : IJMM
|
August 28, 2018
Factors in the emergence of serious human infections associated with highly pathogenic strains of shiga toxin-producing Escherichia coli
Mohamed A Karmali
Meat Science
|
November 9, 2011
Use of comparative genomics as a tool to assess the clinical and public health significance of emerging Shiga toxin-producing Escherichia coli serotypes
Mohamed A Karmali
Journal of Internal Medicine. Supplement
|
January 1, 1989
n-3 fatty acids and cancer
R A Karmali
Page
of 16
Search research articles
Search
Showing results (1-10 of 156) with videos related to
Sort By:
Page
of 16
Molecular Biotechnology
|
February 7, 2004
Infection by Shiga toxin-producing Escherichia coli: an overview
Mohamed A Karmali
Prostaglandins, Leukotrienes, and Medicine
|
October 1, 1987
Modulation of arachidonic acid metabolism in experimental arthritis induced by Salmonella enteritidis. I. Effect of ibuprofen and flurbiprofen on experimental arthritis induced by Salmonella enteritidis
R A Karmali
Kidney International. Supplement
|
January 31, 2009
Host and pathogen determinants of verocytotoxin-producing Escherichia coli-associated hemolytic uremic syndrome
Mohamed A Karmali
Cancer Biochemistry Biophysics
|
June 1, 1984
Growth inhibition and prostaglandin metabolism in the R3230AC mammary adenocarcinoma by reduced glutathione
R A Karmali
Prostaglandins and Medicine
|
July 1, 1980
Review: prostaglandins and cancer
R A Karmali
Nutrition (Burbank, Los Angeles County, Calif.)
|
January 1, 1996
Historical perspective and potential use of n-3 fatty acids in therapy of cancer cachexia
R A Karmali
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 18, 2016
Emerging Public Health Challenges of Shiga Toxin-Producing Escherichia coli Related to Changes in the Pathogen, the Population, and the Environment
Mohamed A Karmali
International Journal of Medical Microbiology : IJMM
|
August 28, 2018
Factors in the emergence of serious human infections associated with highly pathogenic strains of shiga toxin-producing Escherichia coli
Mohamed A Karmali
Meat Science
|
November 9, 2011
Use of comparative genomics as a tool to assess the clinical and public health significance of emerging Shiga toxin-producing Escherichia coli serotypes
Mohamed A Karmali
Journal of Internal Medicine. Supplement
|
January 1, 1989
n-3 fatty acids and cancer
R A Karmali
Page
of 16